FIELD: medicine.
SUBSTANCE: what is presented is a complex therapy using basic antiepileptic drugs, wherein the above basic antiepileptic drugs arepresented valproate, carbamazepine, barbiturate, lamotrigine and levetiracetam in pharmaceutically acceptable doses. Rexod® preparation of recombinant superoxide dismutase 3.2±0.64 million units is additionally administered intravenously into the patient once a day.
EFFECT: invention provides the more effective treatment of epilepsy, thereby reducing a severity and a length of the epileptic attacks, particularly in the patients with drug resistance.
4 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DISEASES, ASSOCIATED WITH REDUCED BDNF PRODUCTION | 2013 |
|
RU2555344C2 |
| EXPRESS-ESTIMATION METHOD FOR EVALUATING EPILEPSY TREATMENT EFFECTIVENESS WITH DEPAKIN INJECTIONS UNDER EEG-CONTROL | 2004 |
|
RU2314803C2 |
| METHOD OF CHILDREN ABSENTIA TREATMENT ASSOCIATED WITH IDIOPATHIC GENERALISED EPILEPSY | 2005 |
|
RU2329761C2 |
| METHOD FOR PREDICTING AND TREATING IDIOPATHIC GENERALIZED EPILEPSY IN CHILDREN | 2005 |
|
RU2297176C2 |
| METHOD FOR EVALUATING EPILEPSY PHARMACOTHERAPY EFFECTIVENESS | 2000 |
|
RU2164688C1 |
| METHOD FOR EFFICIENCY INCREASE IN TREATMENT FOR EPILEPSY | 2007 |
|
RU2339373C1 |
| METHOD OF DETERMINATION OF EFFECTIVE THERAPEUTIC DOSE OF ANTIEPILEPTIC PREPARATION AND RISK OF PROGRESS OF ADVERSE EFFECTS | 2014 |
|
RU2574204C1 |
| METHOD OF THERAPY IN PATIENTS WITH PHARMACOTHERAPY- RESISTANT EPILEPSY FORMS | 2000 |
|
RU2178298C1 |
| DERIVATIVE PYRIDOXIN FOR TREATMENT OF EPILEPSY | 2017 |
|
RU2650523C1 |
| METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINE | 2016 |
|
RU2740919C2 |
